These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 16864615

  • 1. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [Abstract] [Full Text] [Related]

  • 2. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A, Yu H, Oswald H, Luesebrink U, Ludwig A, Pichlmaier AM, Drexler H, Klein G.
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 5. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H, Oswald H, Gardiwal A, Lissel C, Klein G.
    Am J Cardiol; 2007 Aug 15; 100(4):635-9. PubMed ID: 17697820
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Jan 03; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 10. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.
    Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner I, Brueckmann M, Schumacher B, Borggrefe M, Wolpert C.
    Cytokine; 2009 Sep 03; 47(3):166-72. PubMed ID: 19604708
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML, MADIT-II Research Group.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):769-73. PubMed ID: 16487843
    [Abstract] [Full Text] [Related]

  • 13. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, Degroot PJ, PainFREE Rx II Investigators.
    J Am Coll Cardiol; 2005 Jul 19; 46(2):310-6. PubMed ID: 16022960
    [Abstract] [Full Text] [Related]

  • 14. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Zarraga IG, Dougherty CM, MacMurdy KS, Raitt MH.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):739-47. PubMed ID: 22773022
    [Abstract] [Full Text] [Related]

  • 15. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients.
    Stuber T, Eigenmann C, Delacrétaz E.
    Pacing Clin Electrophysiol; 2005 Jul 01; 28(7):702-7. PubMed ID: 16008807
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M, Lipchenca I, Viskin S, Ballman KV, Trusty JM, Gurevitz OT, Luria DM, Eldar M, Hammill SC, Friedman PA.
    J Cardiovasc Electrophysiol; 2004 Jun 01; 15(6):658-64. PubMed ID: 15175060
    [Abstract] [Full Text] [Related]

  • 17. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F, Knaus T, Celebi O, Krebs A, Nitardy A, Habedank D, Dietz R, Stockburger M.
    Europace; 2012 Feb 01; 14(2):224-9. PubMed ID: 21946820
    [Abstract] [Full Text] [Related]

  • 18. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study.
    Streitner F, Kuschyk J, Veltmann C, Brueckmann M, Streitner I, Brade J, Neumaier M, Bertsch T, Schumacher B, Borggrefe M, Wolpert C.
    Cytokine; 2007 Oct 01; 40(1):30-4. PubMed ID: 17851087
    [Abstract] [Full Text] [Related]

  • 19. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M, Block M, Brunn J, Bänsch D, Böcker D, Hammel D, Gietzen F, Breithardt G.
    Z Kardiol; 1996 Nov 01; 85(11):809-19. PubMed ID: 9064943
    [Abstract] [Full Text] [Related]

  • 20. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator.
    De Ferrari GM, Rordorf R, Frattini F, Petracci B, De Filippo P, Landolina M.
    Europace; 2007 Dec 01; 9(12):1151-7. PubMed ID: 17947251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.